Aileron Therapeutics Inc (ALRN)
3.76
-0.06
(-1.57%)
USD |
NASDAQ |
May 03, 16:00
3.76
0.00 (0.00%)
After-Hours: 20:00
Aileron Therapeutics Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
EyePoint Pharmaceuticals Inc | 0.00 |
INVO Bioscience Inc | 3.096 |
Bio-Path Holdings Inc | -- |
SINTX Technologies Inc | 0.0052 |
NovaBay Pharmaceuticals Inc | 0.3431 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 106.01M |
Total Liabilities (Quarterly) | 99.12M |
Shareholders Equity (Quarterly) | 6.887M |